We are live on ! Find out more
MAP

Madison Avenue Partners Portfolio holdings

AUM $2.3B
1-Year Est. Return 115.82%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+115.82%
3 Year Est. Return
+241.12%
5 Year Est. Return
+319.41%
10 Year Est. Return
AUM
$458M
AUM Growth
-$6.62M
Cap. Flow
-$8.76M
Cap. Flow %
-1.91%
Top 10 Hldgs %
95.53%
Holding
21
New
3
Increased
4
Reduced
7
Closed
2

Top Buys

Rank Stock Value
1
IART icon
Integra LifeSciences
IART
+$44.5M
2
FHN icon
First Horizon
FHN
+$16.6M
3
GIII icon
G-III Apparel Group
GIII
+$7.94M
4
MBI icon
MBIA
MBI
+$3.79M
5
OVID icon
Ovid Therapeutics
OVID
+$689K

Sector Composition

Rank Sector Weight
1 Healthcare 28.37%
2 Industrials 27.59%
3 Consumer Discretionary 19.75%
4 Communication Services 11.24%
5 Real Estate 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHC icon
1
Graham Holdings Company
GHC
$4.95B
$115M 25%
200,484
+100
+0% +$57.9K
GIII icon
2
G-III Apparel Group
GIII
$1.48B
$75.4M 16.46%
3,914,869
+461,441
+13% +$7.94M
TBPH icon
3
Theravance Biopharma
TBPH
$874M
$72.6M 15.83%
7,012,226
STGW icon
4
Stagwell
STGW
$1.84B
$51.5M 11.24%
7,147,662
IART icon
5
Integra LifeSciences
IART
$1.54B
$38M 8.3%
+924,667
New +$44.5M
ONL
6
Orion Office REIT
ONL
$149M
$27.1M 5.91%
4,095,901
-400,615
-9% -$2.5M
FHN icon
7
First Horizon
FHN
$12.1B
$20.8M 4.53%
1,843,065
+1,241,791
+207% +$16.6M
MBC icon
8
MasterBrand
MBC
$1.09B
$15.1M 3.3%
1,298,688
-3,243,350
-71% -$31.1M
PFSW
9
DELISTED
PFSweb, Inc.
PFSW
$11.9M 2.6%
2,633,189
OVID icon
10
Ovid Therapeutics
OVID
$435M
$10.8M 2.37%
3,307,605
+203,002
+7% +$689K
MACK
11
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$6.8M 1.48%
553,085
MBI icon
12
MBIA
MBI
$290M
$3.64M 0.79%
+420,826
New +$3.79M
FSP
13
Franklin Street Properties
FSP
$45.6M
$2.9M 0.63%
2,002,653
-3,041,373
-60% -$4.21M
CEE
14
Central and Eastern Europe Fund
CEE
$136M
$1.91M 0.42%
211,030
SLVM icon
15
Sylvamo
SLVM
$1.51B
$1.62M 0.35%
40,163
-59,837
-60% -$2.58M
LNSR icon
16
LENSAR
LNSR
$68.8M
$1.52M 0.33%
357,463
-311,583
-47% -$950K
JRVR icon
17
James River Group Holdings
JRVR
$217M
$1.17M 0.25%
63,887
-309,271
-83% -$6.16M
SFE
18
DELISTED
Safeguard Scientifics, Inc.
SFE
$646K 0.14%
391,459
-11,945
-3% -$20.8K
INDV icon
19
Indivior Pharmaceuticals
INDV
$4.77B
$267K 0.06%
+11,200
New +$257K
AIV
20
Aimco
AIV
$381M
-1,382,889
Closed -$10.6M
SMCI icon
21
Super Micro Computer
SMCI
$19.6B
-2,297,020
Closed -$24.5M

Similar funds

Madison Avenue Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Madison Avenue Partners held 21 positions worth $458M, down 1.4% from $465M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Madison Avenue Partners's Q2 2023 filing shows 3 new, 4 increased, 7 reduced and 2 closed positions. Its largest new stake was Integra LifeSciences: 924,667 shares worth $38M. The largest sale was MasterBrand, an estimated $31.1M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Madison Avenue Partners's largest Q2 2023 buy was Integra LifeSciences: 924,667 shares worth $38M.
  • Madison Avenue Partners added most to First Horizon in Q2 2023, an estimated $16.6M increase.
  • Madison Avenue Partners's biggest Q2 2023 reduction was MasterBrand, cutting an estimated $31.1M.
  • Madison Avenue Partners fully exited Super Micro Computer in Q2 2023, selling an estimated $24.5M.
  • Madison Avenue Partners's ten largest holdings make up 96% of its $458M portfolio in Q2 2023.
  • Madison Avenue Partners opened 3 new positions and closed 2 in Q2 2023.
  • Madison Avenue Partners's portfolio value fell 1.4% quarter-over-quarter to $458M.

Based on Madison Avenue Partners's 13F filing for Q2 2023, filed 14 Aug 2023.